Eswatini vs New Zealand: Access to anti-retroviral drugs, male
Eswatini
84.0%
in 2024
New Zealand
85.0%
in 2024
Eswatini rank
36th
New Zealand rank
34th
Access to anti-retroviral drugs, male over time
- Eswatini
- New Zealand
How they compare
New Zealand currently reports 85.0% against 84.0% in Eswatini, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was New Zealand ahead.
Eswatini ranks 36th and New Zealand ranks 34th of 141 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 41.9% | 35.2% | New Zealand |
| 2010s | 48.4% | 63.7% | 15.3% | New Zealand |
| 2020s | 78.8% | 80.0% | 1.2% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Eswatini or New Zealand?
- New Zealand, at 85.0% against 84.0% in Eswatini as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Eswatini and New Zealand?
- 1.0%, with New Zealand ahead.
- How many years of comparable data are there for Eswatini and New Zealand?
- 25 years are reported by both, from 2000 to 2024.
- How do Eswatini and New Zealand rank globally for access to anti-retroviral drugs, male?
- Eswatini ranks 36th and New Zealand ranks 34th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.